Primary prevention of cardiovascular disease with HRT. - Wikidata - wikimedia - TriplyDB

Primary prevention of cardiovascular disease with HRT.

Primary prevention of cardiovascular disease with HRT.

http://www.wikidata.org/entity/Q37968650

about

Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins Cardiovascular risk assessment in women - an update.Risks and benefits of hormone therapy: has medical dogma now been overturned?Menopause and cardiovascular disease.

P2860

Q36569423-5190C497-CB34-455A-B903-BD0361751AE8 Q38871997-6B068502-D314-4008-8E7B-ED89F72C1F0E Q44927904-8ADDB035-BEFD-4421-8E9E-25484F16A833 Q50025650-468F9236-DEC4-4C9A-851F-1CA62BA97B2F

P2860

Primary prevention of cardiovascular disease with HRT.

http://www.wikidata.org/entity/Q37968650

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Primary prevention of cardiovascular disease with HRT.

@en

Primary prevention of cardiovascular disease with HRT.

@nl

type

label

Primary prevention of cardiovascular disease with HRT.

@en

Primary prevention of cardiovascular disease with HRT.

@nl

prefLabel

Primary prevention of cardiovascular disease with HRT.

@en

Primary prevention of cardiovascular disease with HRT.

@nl

P1433

Q37968650-A5206B6B-46A0-4EB2-881F-E5518AC5024D

P1476

Q37968650-53903310-2C95-40AB-AD98-E5B7C8B7CD48

P2093

Q37968650-952E5AE3-EE8C-414E-AFCD-3E73D04C860F

Q37968650-9AE10E42-A6E0-4E4D-A5B5-35E0B054AF94

P2860

Q37968650-07435E8D-C0D3-48E7-AB11-23E22BE9D7A5

Q37968650-0888B8FF-AFEE-40D8-8EB4-8224F17A9108

Q37968650-0E1D863F-CE03-4E9C-8561-46C09B0CDABF

Q37968650-13B88DB2-E82D-4A42-89E9-0C9E2FD61368

Q37968650-1CB1A165-9E92-4EB0-9EC5-B64C00C78967

Q37968650-1F4B0313-E342-4C13-B533-7AFAF10B8A46

Q37968650-1F59D969-B659-4A02-8B8C-123D0A32BDBE

Q37968650-2062665B-B13C-42F6-9CA1-8F8A0B0569AC

Q37968650-22822B45-BD2F-48FE-8697-B4EB9752D879

Q37968650-228EAD08-79CD-4B92-9A30-3D54F7A375DB

P304

Q37968650-7E70EF7A-032C-4C45-9FBF-9C1420D3651C

P31

Q37968650-144B703B-758F-454C-8EAC-9E099FC814FE

P356

Q37968650-67EAA052-9B1C-4072-A9DD-637BD15E4CC4

P433

Q37968650-A549DF8F-E8CD-4D29-86E5-78F1BC4CFE37

P478

Q37968650-47E03F53-F32B-430D-826C-3D484DD5FE85

P577

Q37968650-A4C637DC-2340-4498-B90F-377F83735DA1

P698

Q37968650-211DC6BC-1BA8-4096-9D8A-58C532E37327

P921

Q37968650-8E4A40A8-D561-49D8-A32A-4D650C22A6BA

P356

P1433

P1476

Primary prevention of cardiovascular disease with HRT.

@en

P2093

John C Stevenson

http://www.w3.org/2001/XMLSchema#string

Kate Maclaran

http://www.w3.org/2001/XMLSchema#string

P2860

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Increased cardiovascular mortality after early bilateral oophorectomy

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

Lasofoxifene in postmenopausal women with osteoporosis

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

P304

63-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/WHE.11.87

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22171776

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease